News Archive

KU reseachers find statins may hold keys to future cancer treatment
Jan 20, 2017 -- Tomoo Iwakuma, M.D., Ph.D., an associate professor in the Department of Cancer Biology at the University of Kansas Medical Center, and his team have published the first research showing how the use of statins, such as Lipitor (atorvastatin), Crestor (rosuvastatin) and Mevacor (lovastatin), can shut down structurally mutated p53 proteins that can accelerate cancer progression.
KU Medical Center year-in-review
Jan 09, 2017 -- A look back at some of the University of Kansas Medical Center accomplishments that made headlines globally, nationally and locally in 2016

Last modified: Oct 20, 2016
Follow us

KUMC on Facebook  YouTube  Follow Us on Twitter  Instagram